SCHEMBL3288446

SCHEMBL3288446

NCc1cccnc1N1C[C@@]2(Cc3ccccc3)CN(C(=O)O)C[C@@H]12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.34
GRIN2B Q13224 2/20 0.33
BACE1 P56817 2/20 0.33
CYP46A1 Q9Y6A2 2/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 2/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2C19 P33261 1/20 0.32
CHRM2 P08172 1/20 0.32
HSD11B1 P28845 1/20 0.31
ARG1 P05089 2/20 0.31
ARG2 P78540 2/20 0.31
CACNA1G O43497 1/20 0.31
CACNA1H O95180 1/20 0.31
CACNA1I Q9P0X4 1/20 0.31
TSHR P16473 2/20 0.30
HSD17B10 Q99714 2/20 0.30
MAPT P10636 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3287512 1.00 ALDH1A1 (0.34) ALDH1A1GRIN2BBACE1CYP46A1CYP3A4
SCHEMBL3295707 0.84 KDM4E (0.42) ALDH1A1HSD11B1MEN1KMT2A
SCHEMBL3287887 0.84 KDM4E (0.42) ALDH1A1HSD11B1MEN1KMT2A
SCHEMBL651156 0.78 ARG1 (0.39) ALDH1A1GRIN2BCHRM2ARG1ARG2
SCHEMBL651858 0.78 ARG1 (0.39) ALDH1A1GRIN2BCHRM2ARG1ARG2
SCHEMBL651155 0.78 ARG1 (0.39) ALDH1A1GRIN2BCHRM2ARG1ARG2
SCHEMBL3288262 0.75 P2RX7 (0.49)
SCHEMBL3288040 0.75 P2RX7 (0.49)
SCHEMBL653486 0.74 GRIN2B (0.42) ALDH1A1GRIN2BSMN1; SMN2
SCHEMBL649307 0.74 GRIN2B (0.42) ALDH1A1GRIN2BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7723367-B2 Amino-tetrazoles analogues and methods of use ABBOTT LABORATORIES (US) 2010-05-25 US disclosed
US-20080171733-A1 Amino-Tetrazoles Analogues and Methods of Use ABBOTT LABORATORIES (US) 2008-07-17 US disclosed
US-20060052374-A1 Amino-tetrazole analogues and methods of use ABBVIE INC. 2006-03-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171733-A1 Amino-Tetrazoles Analogues and Methods of Use P2RX7, P2RX2, P2RX5 ALDH1A1 3041/4885GRIN2B 254/4885BACE1 1745/4885
US-20060052374-A1 Amino-tetrazole analogues and methods of use P2RX7, P2RX2, P2RX3 ALDH1A1 3045/4885GRIN2B 249/4885BACE1 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.